We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.
PPDO (Poly-p-dioxanone) is a class of aliphatic poly(ether-ester) polymers renowned for their excellent mechanical properties, biocompatibility, and biodegradability. As early as the last century, it was approved by the U.S. FDA for use in manufacturing Class III medical devices. It serves as a key material for producing absorbable sutures, cosmetic lifting threads, ligation clips, abdominal meshes for hernia repair, and other implantable devices. PPDO, along with its copolymers, blends, and composite materials, is also being developed for applications in bone repair, vascular stents, tissue adhesives, drug sustained-release carriers, and aesthetic products such as "ELLANSé" and "SCULPTRA".
As a raw material for medical device products, PPDO is eligible for the Master File registration. This process authorizes medical device registration applicants to reference the Master File as part of their regulation submission materials when applying for medical device registration. Technical documentation for medical device raw materials (excluding in vitro diagnostic reagents) typically includes descriptions of the raw material composition, physicochemical property studies, biological evaluation data, toxicological risk analysis, and process studies.
1) Process Flow
Describe the main production process based on the product manufacturing technology.
2) Referenced Standards
T/CSBME 054-2022 Poly-p-dioxanone (PPDO) Special Material for Absorbable Sutures
3) Physicochemical Properties Studies
Composition, appearance, inherent viscosity, moisture content, melt flow rate, glass transition temperature, melting point, residue on ignition, heavy metal content (as Pb), tin residue, monomer residue, solvent residue, degradability, etc.
4) Biocompatibility
As a raw material for medical devices, PPDO is often combined with various processing aids and dyes during manufacturing. Therefore, the biocompatibility of the raw material alone cannot represent that of the final medical device product. PPDO as a raw material can be preliminarily evaluated through three fundamental biological tests: in vitro cytotoxicity, skin irritation, and sensitization testing. Alternatively, biocompatibility testing can be conducted on the final product in accordance with the GB/T 16886 series standards. For example, when PPDO is used in an absorbable suture with an implantation contact duration of 24 hours to 30 days, the following biological endpoints should be considered: cytotoxicity, sensitization, irritation or intracutaneous reactivity, acute systemic toxicity, subacute toxicity, implantation effects, genotoxicity, etc.
5) Shelf Life and Packaging/Transportation
It is recommended to conduct shelf-life and packaging/transport validation per raw material requirements for medical devices. Relevant testing can be conducted with reference to: Guidance on Registration Documentation for Shelf Life of Passive Implantable Medical Devices, GB/T 19633 series standards, and YY/T 0681 series standards.
6) Others
If necessary, animal study reports or relevant literatures may be provided.
As of July 31, 2025, the National Medical Products Administration (NMPA) has successfully registered 5 PPDO raw material products. The summary is as follows:
No. | Owner Name | Master File Registration Item | Master File Registration Number | Registration/Update Date |
247 | Nanjing Polymer Medical Technology Co., Ltd. | Poly-p-dioxanone (PPDO) Suture Master File | M2023107-000 | 2023/9/18 |
342 | Suzhou Seemine Red Maple Biotech Co., Ltd. | Poly-p-dioxanone (PPDO) Master File | M2024012-000 | 2024/1/23 |
525 | Chengdu POLYMING Medical Materials Technology Co., Ltd. | Poly-p-dioxanone (PPDO) Pellet Master File Registration | M2024195-000 | 2024/6/8 |
909 | Nanjing Puheyuan Medical Materials Co., Ltd. | Medical-grade Poly-p-dioxanone (PPDO) | M2025152-000 | 2025/5/7 |
931 | Ningbo Baoting Biotechnology Co., Ltd. | Poly-p-dioxanone (PPDO) | M2025174-000 | 2025/5/29 |
We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.